GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. - Wikidata - awgldk - TriplyDB

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

http://www.wikidata.org/entity/Q33231170

about

Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome Steering Endogenous Butyrate Production in the Intestinal Tract of Broilers as a Tool to Improve Gut Health Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions.The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis Unmyelinated nerve fibers in the human dental pulp express markers for myelinated fibers and show sodium channel accumulations.Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons Enteral nutrition in the management of pediatric intestinal failure.Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine Emerging treatment options for short bowel syndrome: potential role of teduglutide Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.Porcine models of digestive disease: the future of large animal translational research.Glucagon-like peptide-2-stimulated protein synthesis through the PI 3-kinase-dependent Akt-mTOR signaling pathway.Hepatocyte Growth Factor and MET Support Mouse Enteric Nervous System Development, the Peristaltic Response, and Intestinal Epithelial Proliferation in Response to Injury.Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection.Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility.Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.Defining disease with laser precision: laser capture microdissection in gastroenterology.Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons.Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.Glucagon-like peptide-2 (GLP-2) increases net amino acid utilization by the portal-drained viscera of ruminating calves.The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease.The "cryptic" mechanism of action of glucagon-like peptide-2.Treatment of adult short bowel syndrome patients with teduglutide.Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.Review article: a comparison of glucagon-like peptides 1 and 2.Teduglutide in Crohn's disease.The contribution of neuronal-glial-endothelial-epithelial interactions to colon carcinogenesis.Oral and intestinal sweet and fat tasting: impact of receptor polymorphisms and dietary modulation for metabolic disease.Effect of porcine glucagon-like peptides-2 on tight junction in GLP-2R + IPEC-J2 cell through the PI3 k/Akt/mTOR/p70S6K signalling pathway.Control of chylomicron export from the intestine.Teduglutide for treatment of adult patients with short bowel syndrome.Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.

P2860

Q24629712-C9F34D4F-348A-4583-A468-00FA36432D4D Q26770503-A1263458-7165-4AE2-B2C0-734FCF59507C Q30362026-5B62EF9A-0236-4082-AEC7-18FE481F9214 Q34201215-FDE478A4-6E0E-48C2-9C4A-F795AF14D116 Q34201495-AF4AB074-6873-42CC-BF5A-0B67035628CC Q34215215-2AEB0534-EA65-49EC-B0DA-D7CCA4CCB07B Q34617503-7E1B398B-18F0-494D-BA1B-5AB5E81BFB68 Q34726758-C00A5A1A-6B44-405F-B268-A1ADA33D1812 Q34982361-AC0CC42A-3356-45D6-A1D6-015974CD524C Q35304614-ED633F2B-665A-4473-BEA6-70FAB351E87A Q35429613-F1A40C57-4591-4351-8AE0-07C906752C9A Q35691021-7E5DDABA-C7CA-40E3-9A63-ACA3D396D93B Q35756432-114B0E5B-361E-4936-8073-D98B57463088 Q35968089-E1F423E5-EE61-452A-BA34-939AD4D5F7A8 Q35986076-D03B17C8-256F-45C2-9FD8-CECFDB342C68 Q35994078-0DAFA490-4823-405E-A9BF-8E75AC627C7B Q36063090-66EC59F5-43A8-4A0B-9BF7-170CC0DBBE00 Q36171894-F4F29903-E8D9-4B9C-99C6-ABDC0868ACAE Q36309586-434BFA20-7604-4795-A5B3-661DBFAFC42A Q36312440-607275C9-EC16-4542-A8B1-31258D176112 Q36710034-3B8D5D33-837D-42B6-A05F-071F07ABB99D Q36710038-8B1FA265-3908-4D8D-8819-B44DD8293F38 Q37076843-67533E1E-EEEC-4B52-94E9-CF80E2ED31EC Q37117545-13CADE8C-A597-49BF-A71B-0AE9271B13F2 Q37138788-6371DEA7-2B50-4081-8C88-69718CBDC6CD Q37391813-B54BACCE-D5C9-43A7-B966-54126B50AEAF Q37662980-28B8D9E3-1370-4199-9DC9-C262DB3009EA Q37681059-F70C66CE-558A-4DEB-869A-30A01E3A92E1 Q37840099-7429630B-9096-4EAE-B78A-4AE9C02D3F59 Q37870031-0B8B5A65-7D70-4728-8DBB-9A445943489F Q37973750-A6A6324A-7E04-4A07-BD1B-E6FCFF6687A9 Q38048602-42C259FD-6C54-4699-BBB6-B158358A3C83 Q38057350-5B9C1C82-8366-4061-9A2D-9D15D7024223 Q38120028-7CA1AC25-C468-4143-98BA-7AED1AE45974 Q38213491-8904A058-9CB4-4F69-975E-B4F77A62F4E4 Q38503042-C1583606-98B2-4E6A-BBF8-750BDE5C2BDE Q38718059-CB584331-5E59-49E8-A8CE-0714BB986F91 Q38763876-08842381-C2CD-4C4D-94E8-901DD4BB8317 Q39178858-66F8A58A-7FA7-4760-A388-76183211BD26 Q39585744-32B37B78-3FF3-4CA5-A68A-BE982C7A08E5

P2860

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

http://www.wikidata.org/entity/Q33231170

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@ast

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@en

type

label

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@ast

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@en

prefLabel

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@ast

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@en

P1433

Q33231170-562C3D4B-5692-48E5-BE46-B8957E2CE8CC

P1476

Q33231170-6269F002-61BD-4D6F-8934-E442D2DA3434

P2093

Q33231170-11D6F41A-72AF-48EF-B1CC-7F99FB9F6733

Q33231170-371AD593-5835-4094-8A30-F00E973FC1B6

Q33231170-77177CDE-EAB1-42E4-8CD0-DD52EA404FD5

Q33231170-7B7CBE2C-D26D-4840-B0F6-4B83D570E455

Q33231170-960E2CF2-2666-4F72-A3C3-23AF4EBBBF7E

Q33231170-ADC61A31-EF69-40F5-8DE8-7CB6CB95C246

Q33231170-C33FFA7A-1676-4608-B2AB-B0A90C506B60

Q33231170-DA10A340-2AE4-40EC-AD8C-07017A7B1835

Q33231170-E04C6337-4FDA-4510-994C-41C29EDDBEA5

Q33231170-E0ECE95D-B954-4490-9466-8BA2ACB843B3

P304

Q33231170-FE8BD21C-691D-4DC3-A037-B4818EFC9657

P31

Q33231170-9A451A9F-73F8-42E2-A5EA-9A86F7EF8078

P356

Q33231170-C70854ED-8FBC-443E-A730-7900329E9212

P407

Q33231170-D041B442-D1FA-45E9-A69B-7BE843B90A69

P433

Q33231170-985AAB45-3586-4F88-8744-53D6B31E4CAD

P478

Q33231170-6A5A27EC-0A4E-4D77-B88C-38CE500C1D5E

P50

Q33231170-18776477-FE74-4D3E-B4EF-1FD0AF9CD68C

Q33231170-3B54238B-DA16-42FC-88C2-D135E40412BD

P577

Q33231170-8E15D302-B1B3-4522-912A-37C87DAE9DA8

P5875

Q33231170-AB05D8A4-CB43-45A5-89D0-CAD3E24E7EBF

P698

Q33231170-A851A8EE-D430-4F16-97EA-2A3A4CED962D

P356

J.GASTRO.2005.11.005

P1433

Gastroenterology

P1476

GLP-2 receptor localizes to en ...... mediates increased blood flow.

@en

P2093

Barbara Stoll

http://www.w3.org/2001/XMLSchema#string

Buford L Nichols

http://www.w3.org/2001/XMLSchema#string

Darryl Hadsell

http://www.w3.org/2001/XMLSchema#string

Guangcheng Zhang

http://www.w3.org/2001/XMLSchema#string

Heidi E Karpen

http://www.w3.org/2001/XMLSchema#string

John Stephens

http://www.w3.org/2001/XMLSchema#string

John T Bukowski

http://www.w3.org/2001/XMLSchema#string

Milton J Finegold

http://www.w3.org/2001/XMLSchema#string

Sanyong Niu

http://www.w3.org/2001/XMLSchema#string

Xinfu Guan

http://www.w3.org/2001/XMLSchema#string

P304

150-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2005.11.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Jens Juul Holst

Douglas G Burrin

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7371345

http://www.w3.org/2001/XMLSchema#string

P698

16401478

http://www.w3.org/2001/XMLSchema#string